Spectrix

TargetRadar: Drug Target Validation in 30 Seconds Enterprise tools cost $50-200K/year and take weeks. TargetRadar delivers comprehensive analysis—free, instant, open source. FEATURES: • 7-Dimension Scoring: Genetic Evidence, Chemical Tractability, Structural Readiness, Clinical History, Regulatory Genomics (AlphaGenome), Literature, Innovation—querying Open Targets, ChEMBL, PDB, ClinicalTrials.gov, Ensembl, PubMed, bioRxiv • 16 AI Features (Opus 4.6): Intelligence briefs, competitive analysis, hypothesis generation, conflict detection, trial design • Tools: Molecule Testing Lab, DeepTarget Discovery, 3D visualization, docking, .docx/.xlsx reports Live: http://138.68.7.97:4000 MIT licensed, no login required.